Abstract
The continuing expansion of interest in probiotic bacteria has led to an increase in manufactured Functional Foods and medicines containing these bacteria. Given the intestinal origin of these microorganisms, the challenges these sensitive bacteria face in order to be in a highly viable state throughout processing, storage and gastrointestinal transit to the site of action in the human gut are enormous. These bacteria encounter stresses including temperature, acid, bile, exposure and osmotic and oxidative stress in both product matrices and during gastrointestinal transit. However, like all bacteria, probiotic bacteria retain a broad arsenal of molecular mechanisms to combat the often lethal environmental stresses encountered during processing and following ingestion. A comprehensive appreciation of these mechanisms should inevitably lead to the design and manufacture of probiotic cultures, which retain greater viability through to the target site in the intestine. This review attempts to catalogue the cellular processes available to probiotic bacteria to facilitate survival in stressful conditions, and to speculate on how manipulation of these cellular systems can lead to production of designer strains with enhanced viability in food systems and efficacy following ingestion.
Keywords: Probiotic, lactobacilli, heat shock protein, stress, viability
Current Pharmaceutical Design
Title: Life Under Stress: The Probiotic Stress Response and How it may be Manipulated
Volume: 14 Issue: 14
Author(s): B. M. Corcoran, C. Stanton, G. Fitzgerald and R. P. Ross
Affiliation:
Keywords: Probiotic, lactobacilli, heat shock protein, stress, viability
Abstract: The continuing expansion of interest in probiotic bacteria has led to an increase in manufactured Functional Foods and medicines containing these bacteria. Given the intestinal origin of these microorganisms, the challenges these sensitive bacteria face in order to be in a highly viable state throughout processing, storage and gastrointestinal transit to the site of action in the human gut are enormous. These bacteria encounter stresses including temperature, acid, bile, exposure and osmotic and oxidative stress in both product matrices and during gastrointestinal transit. However, like all bacteria, probiotic bacteria retain a broad arsenal of molecular mechanisms to combat the often lethal environmental stresses encountered during processing and following ingestion. A comprehensive appreciation of these mechanisms should inevitably lead to the design and manufacture of probiotic cultures, which retain greater viability through to the target site in the intestine. This review attempts to catalogue the cellular processes available to probiotic bacteria to facilitate survival in stressful conditions, and to speculate on how manipulation of these cellular systems can lead to production of designer strains with enhanced viability in food systems and efficacy following ingestion.
Export Options
About this article
Cite this article as:
Corcoran M. B., Stanton C., Fitzgerald G. and Ross P. R., Life Under Stress: The Probiotic Stress Response and How it may be Manipulated, Current Pharmaceutical Design 2008; 14 (14) . https://dx.doi.org/10.2174/138161208784480225
DOI https://dx.doi.org/10.2174/138161208784480225 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Strategies for Probing Substrate Specificity of Proteases
Current Medicinal Chemistry Recent Developments in the Pharmacological Properties of 4'-Geranyloxyferulic Acid, a Colon Cancer Chemopreventive Agent of Natural Origin
Current Drug Targets Green Chemistry Approach as a Versatile Platform for Nanoparticles with Biomedical Applications
Nanoscience & Nanotechnology-Asia Development of Flavone Propargyl Ethers as Potent and Selective Inhibitors of Cytochrome P450 Enzymes 1A1 and 1A2
Drug Metabolism Letters Interactions of Metal Ions with DNA, Its Constituents and Derivatives, which may be Relevant for Anticancer Research
Current Topics in Medicinal Chemistry Current Treatments of Primary Sclerosing Cholangitis
Current Medicinal Chemistry Therapeutic Benefits of <i>Piper nigrum</i>: A Review
Current Bioactive Compounds Ganoderma lucidum: A Source for Novel Bioactive Lectin
Protein & Peptide Letters Recent Advances in Predicting Protein Classification and Their Applications to Drug Development
Current Topics in Medicinal Chemistry Quantitative Evaluation of Micronuclei in Oral Squamous Cell Carcinoma and Oral Submucous Fibrosis Patients: A Comparative Study
Recent Patents on Anti-Cancer Drug Discovery Nanoparticle Interaction with Biomolecules: How it Shapes the Nano-Effects on Immunity
Current Bionanotechnology (Discontinued) Predict Drug-Protein Interaction in Cellular Networking
Current Topics in Medicinal Chemistry Chemical and Radiochemical Considerations in Radiolabeling with α-Emitting Radionuclides
Current Radiopharmaceuticals An Evaluation on Different Machine Learning Algorithms for Classification and Prediction of Antifungal Peptides
Medicinal Chemistry Cloning, Characterization and Anti-Inflammatory Properties of <i>Bothrops jararaca</i> Snake Antithrombin
Protein & Peptide Letters Synthesis and Chymotrypsin Inhibitory Activity of Substituted Oxazolones
Letters in Drug Design & Discovery β-Synuclein Assembly as a Therapeutic Target of Parkinsons Disease and Related Disorders
Current Pharmaceutical Design Structure-Based Drug Design, Molecular Dynamics and ADME/Tox to Investigate Protein Kinase Anti-Cancer Agents
Current Bioactive Compounds Full Factorial Experimental Design for Development and Validation of a RP-HPLC Method for Estimation of Letrozole in Nanoformulations
Current Pharmaceutical Analysis Antioxidant Activity of Galantamine and Some of its Derivatives
Current Medicinal Chemistry